← Back to Search

Radiofrequency-Based treatment

Radiofrequency Treatment for Skin Conditions

N/A
Recruiting
Led By Noori Kim
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
For HS patients, participants will have localized disease to the axillae, mild to moderate severity and no evidence of active infection as assessed by the investigator
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

This trial is testing a new way to treat skin conditions using radiofrequency waves.

Who is the study for?
This trial is for adults aged 22-70 with mild to moderate Hidradenitis Suppurativa (HS) localized to the underarms, or healthy individuals. Participants must understand the study and follow procedures, including multiple skin biopsies. Excluded are those on certain medications like blood thinners, immune modulators, systemic steroids; with allergies to anesthetics; active infections; significant medical history; pregnant/nursing women; or a history of severe scarring.Check my eligibility
What is being tested?
The study tests radiofrequency-based treatment's effects on human skin in HS patients and healthy subjects. It aims to determine if this method is feasible by observing how it affects treated areas compared to untreated ones.See study design
What are the potential side effects?
Potential side effects may include reactions at the biopsy site such as pain, swelling, bruising or infection. There might also be risks associated with radiofrequency treatment itself like burns or changes in skin sensation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have HS with localized disease in my armpits, of mild to moderate severity, and no active infections.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Safety of skin-RF interactions in axillary skin
Tolerability of skin-RF interactions in axillary skin

Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy ParticipantsExperimental Treatment1 Intervention
Electrothermolysis treatment using varying levels of RF energies

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,273 Previous Clinical Trials
14,840,342 Total Patients Enrolled
Noori KimPrincipal InvestigatorJohns Hopkins University

Media Library

Radiofrequency-Based treatment (Radiofrequency-Based treatment) Clinical Trial Eligibility Overview. Trial Name: NCT05066113 — N/A
Hidradenitis Suppurativa Research Study Groups: Healthy Participants
Hidradenitis Suppurativa Clinical Trial 2023: Radiofrequency-Based treatment Highlights & Side Effects. Trial Name: NCT05066113 — N/A
Radiofrequency-Based treatment (Radiofrequency-Based treatment) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05066113 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for people under the age of twenty to participate in this research?

"Prospective participants in this trial must be aged between 22 and 70 years old."

Answered by AI

What prerequisites must be fulfilled in order to join this experiment?

"This clinical trial is recruiting 50 individuals between 22 and 70 years old who currently have hidradenitis suppurativa. In order to be eligible, patients must demonstrate the capacity to complete all study requirements including visits as well as provide informed consent. Furthermore, they need to not only be fit enough for a skin biopsy but also able to comprehend and converse with medical personnel."

Answered by AI

Is recruitment for this experiment still active?

"That is correct. According to data posted on clinicaltrials.gov, this medical trial which was originally published on August 15th 2017, continues to recruit participants and has been updated as recently as June 28th 2022. A total of 50 patients are needed from just one site for the study."

Answered by AI

What is the current volume of participants in this clinical trial?

"Indeed, clinicaltrials.gov affirms that this experiment is actively searching for individuals to enroll. It was first posted on August 15th 2017 and has since been updated as recently as June 28th 2022. The trial requires 50 people from a single site to participate in the study."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
Maryland
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
What site did they apply to?
Johns Hopkins School of Medicine
Recent research and studies
clinicaltrials.govStudy
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
2017. "Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05066113.
All > Hidradenitis Suppurativa
~7 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top